Created in 2007 (United States), CINGAL own 9 sister brands and 2214 competing brands. CINGAL is a brand of Anika Therapeutics, listed on the stock exchange of New York. CINGAL is part of the Biotechnology activity sector.
Investment simulator :
Portfolio valuation
Anika Therapeutics
(CINGAL)
over 5 years*
USD 19.87